Suppression of HIV-1 Infectivity by Human Glioma Cells

Area of Science:

• Neurovirology
• Cell Biology

Background:

• Human immunodeficiency virus type 1 (HIV-1) commonly infects the central nervous system (CNS) in AIDS patients, primarily targeting monocytes and macrophages.
• The role of HIV-1-resistant brain cells, such as astrocytes and oligodendrocytes, in modulating CNS infection remains largely unexplored.

Purpose of the Study:

• To investigate the impact of HIV-1-resistant human glioblastoma cell lines on HIV-1 stability and infectivity.
• To determine if these brain cells enhance or suppress HIV-1 infection within the CNS.

Main Methods:

• HIV-1 stability was assessed by culturing the virus with glioblastoma cell lines (NP-2, U87MG, T98G, A172) and measuring viral titer using MAGIC-5A cells and CD4(+) T cells.
• The effect of spent culture media (SCM) from these cell lines on HIV-1 infection was evaluated.
• Enzymatic treatment (chondroitinase ABC, heparinase) was used to identify the inhibitory factors in SCM.

Main Results:

• HIV-1 stability was significantly reduced (half-life 2.5–4 hours) when incubated with NP-2 or U87MG cells compared to T98G, A172 cells, or cell-free medium (half-life 8–18 hours).
• SCM from NP-2 and U87MG cells suppressed both R5- and X4-HIV-1 infection by inhibiting viral attachment.
• The inhibitory effect was abolished by chondroitinase ABC treatment, indicating involvement of chondroitin sulfate (CS) or CS-like molecules.

Conclusions:

• Certain glioma cell lines (NP-2, U87MG) secrete inhibitory factors, primarily chondroitin sulfate, that reduce HIV-1 stability and infectivity.
• These findings suggest that glioma cells can modulate HIV-1 infection in the CNS, potentially contributing to lower viral loads in vivo.